168 related articles for article (PubMed ID: 37033343)
1. Assessment of the prognostic and clinicopathological significance of HOXA-AS2 in human cancers: a systematic review and meta-analysis.
Lu B; Liu Z; Ji X; Zhang X
Transl Cancer Res; 2023 Mar; 12(3):605-615. PubMed ID: 37033343
[TBL] [Abstract][Full Text] [Related]
2. HOXA-AS2 may be a potential prognostic biomarker in human cancers: A meta-analysis and bioinformatics analysis.
Zhang F; Zhang G; Zhang H; Pu X; Chi F; Zhang D; Xin X; Gao M; Luo W; Li X
Front Genet; 2022; 13():944278. PubMed ID: 36437956
[No Abstract] [Full Text] [Related]
3. LncRNA HOXA‑AS2 is a prognostic and clinicopathological predictor in patients with cancer: A meta‑analysis.
Xiao T; Yan A; Tan L; Zhu H; Gao W
Oncol Lett; 2024 May; 27(5):226. PubMed ID: 38586205
[TBL] [Abstract][Full Text] [Related]
4. HOXA-AS2 may predict the prognosis of solid tumors among Chinese patients: A meta-analysis and bioinformatic analysis.
Wang Q; Zhang W; Deng C; Lin S; Zhou Y
Front Oncol; 2022; 12():1030825. PubMed ID: 36387249
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of long non-coding RNA HOXA-AS2 in non-small cell lung cancer is associated with worse survival outcome.
Li Y; Jiang H
Int J Clin Exp Pathol; 2017; 10(9):9690-9696. PubMed ID: 31966850
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive investigation of the clinical significance of long non-coding RNA HOXA-AS2 in acute myeloid leukemia using genome-wide RNA sequencing dataset.
Huang R; Liao X; Wang X; Li Q
J Cancer; 2021; 12(7):2151-2164. PubMed ID: 33754013
[No Abstract] [Full Text] [Related]
7. Long non-coding RNA HOXA-AS2 promotes the migration, invasion and stemness of bladder cancer via regulating miR-125b/Smad2 axis.
Wang F; Wu D; Chen J; Chen S; He F; Fu H; Wu Q; Liu S; Li X; Wang W
Exp Cell Res; 2019 Feb; 375(1):1-10. PubMed ID: 30412716
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA HOXA-AS2 promotes gastric cancer proliferation by epigenetically silencing P21/PLK3/DDIT3 expression.
Xie M; Sun M; Zhu YN; Xia R; Liu YW; Ding J; Ma HW; He XZ; Zhang ZH; Liu ZJ; Liu XH; De W
Oncotarget; 2015 Oct; 6(32):33587-601. PubMed ID: 26384350
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of HOXA-AS2 LncRNA in Patients with Gastric Cancer and Its Association with Helicobacter pylori Infection.
Rajabi A; Riahi A; Shirabadi-Arani H; Moaddab Y; Haghi M; Safaralizadeh R
J Gastrointest Cancer; 2022 Mar; 53(1):72-77. PubMed ID: 33174119
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA HOXA-AS2 promotes proliferation and invasion of breast cancer by acting as a miR-520c-3p sponge.
Fang Y; Wang J; Wu F; Song Y; Zhao S; Zhang Q
Oncotarget; 2017 Jul; 8(28):46090-46103. PubMed ID: 28545023
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Long Noncoding RNA CRNDE as a Novel Biomarker in Solid Cancers: An Updated Systematic Review and Meta-Analysis.
Zhou Y; Wang R; Xu T; Xie P; Zhang Y; Zhang A; Wang X; Yang C; Yang H; Zhu S
J Cancer; 2019; 10(11):2386-2396. PubMed ID: 31258743
[No Abstract] [Full Text] [Related]
12. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value and therapeutic potential of the long noncoding RNA TP73-AS1 in cancers: A systematic review and meta-analysis.
Zhong Y; Zhao M; Yu Y; Li Q; Wang F; Wu P; Zhang W; Miao L
Sci Rep; 2020 Jun; 10(1):9053. PubMed ID: 32493915
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA HOXA-AS2 promotes non-small cell lung cancer progression by regulating miR-520a-3p.
Liu Y; Lin X; Zhou S; Zhang P; Shao G; Yang Z
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31064819
[No Abstract] [Full Text] [Related]
15. TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis.
Chen C; Wang J; Feng Y; Liang Y; Huang Y; Zou W
BMC Cancer; 2022 May; 22(1):581. PubMed ID: 35614413
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of long noncoding RNA HOXA-AS2 predicts an adverse prognosis and promotes tumorigenesis via SOX4/PI3K/AKT pathway in acute myeloid leukemia.
Qu Y; Wang Y; Wang P; Lin N; Yan X; Li Y
Cell Biol Int; 2020 Aug; 44(8):1745-1759. PubMed ID: 32369230
[TBL] [Abstract][Full Text] [Related]
17. HOX Antisense lincRNA HOXA-AS2 Promotes Tumorigenesis of Hepatocellular Carcinoma.
Wang F; Yang H; Deng Z; Su Y; Fang Q; Yin Z
Cell Physiol Biochem; 2016; 40(1-2):287-296. PubMed ID: 27855366
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.
Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G
BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912
[TBL] [Abstract][Full Text] [Related]
19. Clinical Value of Long Noncoding RNA HOTAIR as a Novel Biomarker in Digestive Cancers: A Meta-Analysis.
Zhang Y; Zhou Y; Xu T; Tian W; Yang C; Wang X; Zhong S; Ran Q; Yang H; Zhu S
Technol Cancer Res Treat; 2018 Jan; 17():1533034618756783. PubMed ID: 29444619
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of long noncoding RNA SNHG16 on clinical outcomes in human cancers: a systematic review and meta-analysis.
Zhang C; Ren X; He J; Wang W; Tu C; Li Z
Cancer Cell Int; 2019; 19():261. PubMed ID: 31632195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
